| Other Names | rolipram, 61413-54-5, (R, S)-rolipram, (+/-)-Rolipram, Rolipramum [Latin], ZK 62711, Rolipramum, 4-(3-(cyclopentyloxy)-4-methoxyphenyl)pyrrolidin-2-one, 4-[3-(Cyclopentyloxy)-4-methoxyphenyl]-2-pyrrolidinone, 4-[3-(cyclopentyloxy)-4-methoxyphenyl]pyrrolidin-2-one, Adeo, ZK-62711, Rolipram [USAN:INN], 4-(3-cyclopentyloxy-4-methoxyphenyl)pyrrolidin-2-one, 4-(3-(Cyclopentyloxy)-4-methoxyphenyl)-2-pyrrolidinone, 4-(3-Cyclopentyloxy-4-methoxyphenyl)-2-pyrrolidone, EINECS 262-771-1, NSC-760125, BRN 1588548, DTXSID3044124, ZK 62 711, CHEBI:104872, K676NL63N7, ROLIPRAM [USAN], ROLIPRAM [INN], ROLIPRAM [JAN], ROLIPRAM [MI], CHEMBL63, ROLIPRAM [MART.], ROLIPRAM [WHO-DD], SB 95952, SB-95952, ZK-62771, MLS000069691, 2-Pyrrolidinone, 4-[3-(cyclopentyloxy)-4-methoxyphenyl]-, DTXCID1024124, Rolipramum (Latin), NSC 760125, 2-Pyrrolidinone, 4-(3-(cyclopentyloxy)-4-methoxyphenyl)-, SMR000058510, ROLIPRAM (MART.), (R, S)-Rolipram SB 95952 ZK 62711, 4-(3-(cyclopentyloxy)-4-methoxyphenyl)-2-pyrrolidinon, 4-(3-Cyclopentyloxy-4-methoxy-phenyl)-pyrrolidin-2-one, 4-(3-CYCLOPENTYLOXY-4-METHOXYPHENYL)PYRROLIDONE, (R)-4-(3-(cyclopentyloxy)-4-methoxyphenyl)pyrrolidin-2-one, (4R)-4-[3-(Cyclopentyloxy)-4 Methoxyphenyl)pyrrolidin-2-one, (4S)-4-[3-(Cyclopentyloxy)-4-methoxyphenyl]-pyrrolidin-2-one, R-(-)-Rolipram, [3H]rolipram, [3H]-rolipram, SR-01000000162, 4-(3-cyclopentyloxy-4-methoxyphenyl)-2-pyrrolidinone, 4-[3-Cyclopentyloxy-4-methoxyphenyl]-2-pyrrolidinone, UNII-K676NL63N7, Rolipram?, (plusmn)-rolipram, NCGC00016899-01, (+-)-rolipram, CAS-61413-54-5, MFCD00270906, Rolipram (Standard), Pyrrolidone, 4-(3-cyclopentyloxy-4-methoxyphenyl)-2-, ME-3167, Opera_ID_1749, Prestwick0_000924, Prestwick1_000924, Prestwick2_000924, Prestwick3_000924, UPCMLD-DP110, Lopac0_001072, SCHEMBL27930, BSPBio_000828, BSPBio_001356, KBioGR_000076, KBioSS_000076, Rolipram (JAN/USAN/INN), MLS000758273, MLS000759531, MLS001146912, MLS001424084, MLS006010272, SPBio_003007, (+)-Rolipram (S)-Rolipram, BPBio1_000912, GTPL5260, GTPL5313, 4-[3-(cyclopentoxy)-4-methoxy-phenyl]pyrrolidin-2-one, UPCMLD-DP110:001, UPCMLD-DP110:002, BDBM14361, KBio2_000076, KBio2_002644, KBio2_005212, KBio3_000151, KBio3_000152, Bio2_000076, Bio2_000556, HMS1361D18, HMS1570J10, HMS1791D18, HMS1989D18, HMS2051N15, HMS2090J16, HMS2097J10, HMS2232F06, HMS3263G06, HMS3267A05, HMS3369J08, HMS3393N15, HMS3402D18, HMS3411F08, HMS3654P06, HMS3655J21, HMS3675F08, HMS3714J10, Pharmakon1600-01505683, BCP21910, BCP23388, Tox21_110672, Tox21_501072, EX-A10913, HB2896, HY-16900R, NSC760125, Rolipram, solid, >=98% (HPLC), s1430, Rolipram – CAS 61413-54-5, AKOS015959793, Tox21_110672_1, CCG-100965, CCG-205149, CS-1754, DB01954, FR01270, KS-1400, LP01072, NC00215, SB12922, SDCCGSBI-0051042.P003, IDI1_033826, NCGC00015898-03, NCGC00015898-04, NCGC00015898-05, NCGC00015898-06, NCGC00015898-07, NCGC00015898-08, NCGC00015898-09, NCGC00015898-11, NCGC00015898-12, NCGC00015898-15, NCGC00015898-31, NCGC00089796-02, NCGC00089796-04, NCGC00089796-05, NCGC00089796-06, NCGC00089796-07, NCGC00089796-08, NCGC00261757-01, AC-32927, HY-16900, SBI-0051042.P002, DB-080675, AB00513966, EU-0101072, NS00034678, R0110, SW196583-4, D01783, R 6520, AB00384360-17, AB00384360_19, Q410285, 4-[3-(cyclopentyloxy)-4-methoxyphenyl]pyrrolidinone, SR-01000000162-3, SR-01000000162-4, SR-01000000162-5, SR-01000000162-9, BRD-A34255068-001-04-8, BRD-A34255068-001-26-1, BRD-A34255068-001-32-9, BRD-A34255068-001-33-7, BRD-A34255068-001-34-5, SR-01000000162-12, 4-(3-cyclopentyloxy-4-methoxy-phenyl)pyrrolidin-2-one, 4-(3-cyclopentyloxy-4-methoxyphenyl)-pyrrolidin-2-one, 4-[4-Methoxy-3-(cyclopentyloxy)phenyl]-2-pyrrolidinone, 2-Pyrrolidinone, 4-[3-(cyclopentyloxy)-4-methoxyphenyl]- (9CI), 262-771-1 |
|---|---|
| IUPAC Name | 4-(3-cyclopentyloxy-4-methoxyphenyl)pyrrolidin-2-one |
| CAS | 3939-14-8 |
| Molecular Weight | 275.34 |
| Molecular Formula | C16H21NO3 |
| SMILES | COC1=C(C=C(C=C1)C2CC(=O)NC2)OC3CCCC3 |


![1H-Pyrrolo[2,3-b]pyridine, 5-chloro-6-methyl- - (1000340-18-0)](https://eontrading.uk/wp-content/uploads/2025/04/1000340-18-0.png)



